Abstract
Approximately 150 years ago the term myocarditis was used indiscriminately to describe virtually all disorders involving the myocardium. Lack of precision in terminology and definition hindered progress, but by the 1950s, Mattingly, Birch and Proctor Harvey in the United States were diligently collecting and studying cases of heart muscle disease. At this time, terms such as “myocardopathy” and “myocardiopathy” were often used [1]. The term “cardiomyopathy” was probably first used by Bridgen in 1957 [2] to describe conditions involving the myocardium, but not due to coronary artery disease. He described these as “non-coronary cardiomyopathies”. Gradually, the cardiomyopathies came to be distinguished from myocarditis, which now is properly defined as “inflammation of the myocardium due to infection, autoimmune response, rejection, allergy or toxic agents”.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Goodwin JF (1979) Cardiomyopathy: an interface between fundamental and clinical cardiology. In: Hayasi S, Muraos (eds) Proceding of the VIII world congress of Cardiology. Excerpta Med. International congress series 470. Elsevier, Amsterdam, p 10
Brigden W (1957) Uncommon myocardial diseases — the non-coronary cardiomyopathies. Lancet 2: 1179–1243
Goodwin JF, Hollman A, Bishop MB (1961) Clinical aspects of cardiomyopathy. Br Med J 1: 69
Goodwin JF (1964) Cardiac function in primary myocardial disorders. Br Med J 1: 1527–1595
Goodwin JF (1970) Congestive and hypertrophic cardiomyopathies — a decade of study. Lancet 1: 731
Goodwin JF, Oakley CM (1972) Editorial; the cardiomyopathies. Br Heart J 34: 545
Goodwin JF (1974) Prospects and predictions for the cardiomyopathies. Circulation 50: 210
Kawai C (1971) Idiopathic cardiomyopathy, a study on the infectious-immune theory as a course of the disease. Jpn Circ J 35: 765
Cambridge G, MacArthur CGC, Waterson AP, Goodwin JF, Oakley CM (1979) Antibodies to coxsackie B virus in congestive cardiomyopathy. Br Heart J 41: 693
Quigley PJ, Richardson PJ, Meany BT, Olsen EGJ, Monagham MJ, Jackson G, Jewitt DE (1978) Long term follow up of acute myocarditis. Correlation of ventricular function and outcome. Eur Heart J 8 (Suppl): 39
Abelman WH (1988) Myocarditis as a cause of dilated cardiomyopathy. In: Engelmeier RS, O’Conncll JG (eds) Drug therapy in dilated cardiomyopathy and myocarditis. Dekker, New York, p 221
Haber E, Yasuda T, Palacios IF, Kwaw WG (1987) Scintigraphy in the diagnosis of acute myocarditis. In: Kuwaii C, Abelman W (eds) Pathogenesis of myocarditis and cardiomyopathy. University of Tokyo Press, Tokyo, p 277
O’Connell JB, Mason JW (1987) Scintigraphy in the diagnosis of acute myocarditis. In: Kawai C, Abelman W (eds) Pathogenesis of myocarditis and cardiomyopathy. University of Tokyo Press, Tokyo, p 281
Bowles NE, Richardson PJ, Olsen EG J, Archard LC (1986) Detection of coxsackie B- virus-specific-RNA sequences in myocardial biopsy from cases of myocarditis and cardiomyopathy. Lancet 1: 1120
Report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies (1980) Br Heart J 44: 672
Report of WHO Expert Committee (1984) Cardiomyopathies. WHO technical report series 697. WHO, Geneva
Liovillie H (1869) Rétrécissement cardiaque sous aortique. Gazette Med Paris 24: 161
Hallopeau M (1869) Rétrécissement ventriculo-aortique. Gazette Med Paris 24: 683
Schminke A (1907) Uber linksartige musculôse Conenstenosen. Dtsch Med Wochensch 33: 2082
Brock R (1957) Functional obstruction of the left ventricle (acquired subvalvar aortic stenosis). Guy’s Hosp Rep 106: 221
Teare D (1958) Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20: 1
Braunwald E, Morrow AG, Cornell WP, Aygen MM, Hilbish TF (1960) Idiopathic hypertrophic subaortic stenosis. Clinical, haemodynamic, angiographic manifestations. Am J Med 29: 924
Goodwin JF, Holman A, Clel WP, Teare D (1960) Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 22: 403
Cohen J, Effat H, Goodwin JF, Oakley CM, Steiner RE (1964) Hypertrophic obstructive cardiomyopathy. Br Heart J 26: 16
Wigle ED, Heimbecker RO, Gunton RW (1962) Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 26: 325
Wigle ED, Henderson M, Sasson Z, Pollick C, Rakowski H (1985) Muscular subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for obstruction to left ventricular outflow. In: Goodwin JF (ed) Heart muscle disease. MTP Press, London, p 217
Criley JM, Siegel RJ (1985) A non-obstructive view of hypertrophic cardiomyopathy. In: Goodwin JF (ed) Heart muscle disease. MTP Press, London, p 157
Murgo JP, Miller JW (1985) Haemodynamic, angiographic and echocardiographic evidence against impeded ejection in hypertrophic cardiomyopathy. In: Goodwin JF (ed) Heart muscle disease. MTP Press, London, p 187
Perloff JK (1985) Pathogenesis of hypertrophic cardiomyopathy. In: Goodwin JF (ed) Heart muscle disease. MTP Press, London, p 7
Davies JNP (1948) Endomyocardial fibrosis in Africa. East Afr Med J 25: 10
Olsen EG J, Spry CJF (1979) The pathogenesis of Loffler’s endomyocardial disease and its relationship to endomyocardial fibrosis. In: Yu PN, Goodwin JF (eds) Progress in cardiology, vol 8. Lea and Febiger, Philadelphia, p 281
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Goodwin, J.F. (1990). Introduction: Thirty Years of Cardiomyopathy. In: Baroldi, G., Camerini, F., Goodwin, J.F. (eds) Advances in Cardiomyopathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83760-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-83760-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83762-3
Online ISBN: 978-3-642-83760-9
eBook Packages: Springer Book Archive